Activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2, in adenocarcinoma of the lung with HER2neu kinase domain mutations

Jacques De Greve; Erik Teugels; Caroline Geers; Johan De Mey; Pieter In 'T Veld; Lore Decoster; Martine Taton; Mehdi Shahidi; D. Galdermans; Denis Schallier

Activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2, in adenocarcinoma of the lung with HER2neu kinase domain mutations

Jacques De Greve, Erik Teugels, Caroline Geers, Johan De Mey, Pieter In 'T Veld, Lore Decoster, Martine Taton, Mehdi Shahidi, D. Galdermans, Denis Schallier

Onderzoeksoutput: Meeting abstract (Journal)

Originele taal-2	English
Pagina's (van-tot)	555-556
Aantal pagina's	2
Tijdschrift	European Journal of Cancer. Supplement
Volume	7
Nummer van het tijdschrift	September
Status	Published - 2009
Evenement	Unknown - Duur: 1 jan 2009 → …

Toegang tot document

http://apps.isiknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=31&SID=S1Kb4d7m3ndp3Fe8AfL&page=1&doc=6&colname=WOS

Citeer dit

De Greve, J., Teugels, E., Geers, C., De Mey, J., In 'T Veld, P., Decoster, L., Taton, M., Shahidi, M., Galdermans, D., & Schallier, D. (2009). Activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2, in adenocarcinoma of the lung with HER2neu kinase domain mutations. European Journal of Cancer. Supplement, 7(September), 555-556. http://apps.isiknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=31&SID=S1Kb4d7m3ndp3Fe8AfL&page=1&doc=6&colname=WOS

De Greve, Jacques ; Teugels, Erik ; Geers, Caroline ; De Mey, Johan ; In 'T Veld, Pieter ; Decoster, Lore ; Taton, Martine ; Shahidi, Mehdi ; Galdermans, D. ; Schallier, Denis. / Activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2, in adenocarcinoma of the lung with HER2neu kinase domain mutations. In: European Journal of Cancer. Supplement. 2009 ; Vol. 7, Nr. September. blz. 555-556.

@article{e1eeda1547364288b53a955a65b4267c,

title = "Activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2, in adenocarcinoma of the lung with HER2neu kinase domain mutations",

keywords = "adenocarcinoma, lung cancer, EGFR",

author = "{De Greve}, Jacques and Erik Teugels and Caroline Geers and {De Mey}, Johan and {In 'T Veld}, Pieter and Lore Decoster and Martine Taton and Mehdi Shahidi and D. Galdermans and Denis Schallier",

year = "2009",

language = "English",

volume = "7",

pages = "555--556",

journal = "European Journal of Cancer. Supplement",

issn = "1359-6349",

publisher = "Elsevier Limited",

number = "September",

note = "null ; Conference date: 01-01-2009",

}

De Greve, J, Teugels, E, Geers, C , De Mey, J , In 'T Veld, P , Decoster, L, Taton, M, Shahidi, M, Galdermans, D & Schallier, D 2009, 'Activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2, in adenocarcinoma of the lung with HER2neu kinase domain mutations', European Journal of Cancer. Supplement, vol. 7, nr. September, blz. 555-556. <http://apps.isiknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=31&SID=S1Kb4d7m3ndp3Fe8AfL&page=1&doc=6&colname=WOS>

Activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2, in adenocarcinoma of the lung with HER2neu kinase domain mutations. / De Greve, Jacques; Teugels, Erik; Geers, Caroline ; De Mey, Johan ; In 'T Veld, Pieter ; Decoster, Lore; Taton, Martine; Shahidi, Mehdi; Galdermans, D.; Schallier, Denis.

In: European Journal of Cancer. Supplement, Vol. 7, Nr. September, 2009, blz. 555-556.

Onderzoeksoutput: Meeting abstract (Journal)

TY - JOUR

T1 - Activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2, in adenocarcinoma of the lung with HER2neu kinase domain mutations

AU - De Greve, Jacques

AU - Teugels, Erik

AU - Geers, Caroline

AU - De Mey, Johan

AU - In 'T Veld, Pieter

AU - Decoster, Lore

AU - Taton, Martine

AU - Shahidi, Mehdi

AU - Galdermans, D.

AU - Schallier, Denis

PY - 2009

Y1 - 2009

KW - adenocarcinoma

KW - lung cancer

KW - EGFR

M3 - Meeting abstract (Journal)

VL - 7

SP - 555

EP - 556

JO - European Journal of Cancer. Supplement

JF - European Journal of Cancer. Supplement

SN - 1359-6349

IS - September

Y2 - 1 January 2009

ER -